Gyeonggi-do, South Korea

Geun-Hyeog Lee

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Hanlim Pharmaceutical Co., Ltd., Catholic University Academic Cooperation Foundation, Catholic University Industry Academic Cooperation Foundation. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geun-Hyeog Lee. Retrieved from https://idiyas.com/inventor/geun-hyeog-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2014 - 2016)
  • Yongin-si, KR (2019 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Geun-Hyeog Lee: Advancements in Ophthalmology

Introduction

Geun-Hyeog Lee is an esteemed inventor hailing from Gyeonggi-do, South Korea. With a remarkable portfolio of five patents, he has made significant contributions to the field of ophthalmology, particularly in developing innovative eye drop formulations aimed at treating and preventing macular degeneration.

Latest Patents

Among his latest inventions, Lee has developed an eye drop formulation that comprises a benzopyran derivative or its pharmaceutically acceptable salt. This formulation includes key ingredients such as propylene glycol as a stabilizing agent and a pH-controlling agent, creating an eye drop solution with a pH ranging from 4.0 to 5.0. His innovations ensure high concentration and excellent stability for the active component, which is designed to be effective in preventing or treating macular degeneration. Additionally, the eye drop formulation can be stored for extended periods, representing a significant advancement in pharmaceutical compositions for eye health.

Career Highlights

Geun-Hyeog Lee has had a fruitful career, contributing to the advancements in pharmaceuticals through his innovative research and development efforts. He has earned accolades for his work at various esteemed organizations, including Hanlim Pharmaceutical Co., Ltd. and the Catholic University Academic Cooperation Foundation. His expertise and contributions have paved the way for significant improvements in ophthalmic treatments.

Collaborations

In his professional journey, Lee has collaborated with notable individuals in the field, including Jin-Ha Park and Byong-Sun Choi. These collaborations have enriched his research endeavors and further strengthened the impact of his inventions in the pharmaceutical industry.

Conclusion

Geun-Hyeog Lee's innovative spirit and dedication to advancing ophthalmic solutions have established him as a prominent figure in the field of ophthalmology. His patents continue to pave the way for improved treatments for macular degeneration, highlighting the importance of innovation in enhancing healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…